Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Agricultural Inputs

Bayer CropScience Limited engages in the manufacture, sale, and distribution of insecticides, fungicides, herbicides, and various other agrochemical products and corn seeds in India, Germany, Bangladesh, and internationally. It provides medicines primarily in the therapeutic areas of cardiology, gynecology, diabetes, oncology, and ophthalmology; and computed tomography, X-Ray, and magnetic resonance imaging devices. In addition, the company offers consumer health products that are used as a daily health solution to treat minor illnesses, as well as sells and distributes hybrid seeds, such as corn and paddy. Further, it provides digital farming products comprising FarmRise and other digital applications, such as drones for spray services, etc., as well as provides various technologies, such as remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics to monitor and manage crop growth, soil quality, weather patterns, and other factors. The company also exports its products. Bayer CropScience Limited was founded in 1863 and is based in Thane, India.

Revenue projections:

Revenue projections for BAYERCROP
Revenue projections for BAYERCROP

Investors are expected to be cautious with Bayer CropScience Limited, as its revenues are projected to fall compared to last year. A decline in revenue often results in a negative impact on profitability, prompting concerns about the company's financial stability and making investors more conservative in their approach.

Financial Ratios:

currentRatio 2.01100
forwardPE 32.05706
debtToEquity 3.68700
earningsGrowth 0.49300
revenueGrowth 0.32200
grossMargins 0.37903
operatingMargins 0.13045
trailingEps 126.14000
forwardEps 0.00000

BAYERCROP's current ratio of 2.011 reflects its strong liquidity position. The company has enough cash reserves and current assets to service its short-term debt obligations, signaling that BAYERCROP is financially well-prepared to meet its liabilities without difficulty.
With earnings and revenue growth in positive territory, Bayer CropScience Limited is projected to expand its business. This strong financial performance suggests the company will continue to grow, as increased profitability and sales drive future success.

Price projections:

Price projections for BAYERCROP
Price projections for BAYERCROP

Bayer CropScience Limited's price has consistently hovered around the lower limit of price projections. This pattern suggests that the stock may be underperforming relative to expectations, which could lead to concerns among investors.

Recommendation changes over time:

Recommendations trend for BAYERCROP
Recommendations trend for BAYERCROP


Analysts have shown a buy bias for Bayer CropScience Limited, signaling it as a strong investment choice. This positive outlook could motivate investors to allocate funds to Bayer CropScience Limited, seeing it as a reliable and potentially profitable option, especially in an environment where the stock market is highly scrutinized.